Medication-info.com Search Menu

Udenyca (Pegfilgrastim): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
6 mg/0.6 mL
Active ingredient:

Patient information: uses, side effects, how to take - Udenyca

What is UDENYCA?

UDENYCA is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance produced by the body. It stimulates the growth of neutrophils, a type of white blood cell important in the body’s fight against infection.

Acute Radiation Syndrome: The effectiveness of pegfilgrastim for this use was only studied in animals, because it could not be studied in people.

Do not take UDENYCAif you have had a serious allergic reaction to pegfilgrastim products or filgrastim products.

Before you receive UDENYCA, tell your healthcare provider about all of your medical conditions, including if you:

  • have a sickle cell disorder.
  • have kidney problems.
  • are pregnant or plan to become pregnant. It is not known if UDENYCA will harm your unborn baby.

  • are breastfeeding or plan to breastfeed. It is not known if UDENYCA passes into your breast milk.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive UDENYCA?

  • UDENYCA is given as an injection under your skin (subcutaneous injection) by a healthcare provider. If your healthcare provider decides that the subcutaneous injections can be given at home by you or your caregiver, follow the detailed "Instructions for Use" that comes with your UDENYCA for information on how to prepare and inject a dose of UDENYCA.
  • You and your caregiver will be shown how to prepare and inject UDENYCA before you use it.
  • UDENYCA comes in a prefilled syringe or a prefilled autoinjector. Your healthcare provider will prescribe the type of UDENYCA that is right for you.
  • Only adults can self-inject UDENYCA with the prefilled autoinjector.
  • You should not inject a dose of UDENYCA to children weighing less than 45 kg from a UDENYCA prefilled syringe. or prefilled autoinjector. A dose less than 0.6 mL (6 mg) cannot be accurately measured using the UDENYCA prefilled syringe or prefilled autoinjector.
  • If you are receiving UDENYCA because you are also receiving chemotherapy, the last dose of UDENYCA should be injected at least 14 days before and 24 hours after your dose of chemotherapy.
  • If you miss a dose of UDENYCA, talk to your healthcare provider about when you should give your next dose.
  • When using the UDENYCA prefilled autoinjector:

    • You may miss your dose or may not receive your full dose if you lift the prefilled autoinjector before you hear the second "click" or if the orange indicator does not completely fill the viewing window.
    • Call your healthcare provider right away if this happens, as you may need a replacement dose of UDENYCA.

What are possible side effects of UDENYCA?

UDENYCA may cause serious side effects, including:

  • Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in the left upper stomach area or your left shoulder.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
  • Serious allergic reactions. UDENYCA can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using UDENYCA and call your healthcare provider or get emergency medical help right away.
  • Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive UDENYCA. Serious sickle cell crises have happened in people with sickle cell disorders receiving pegfilgrastim that has sometimes led to death. Call your healthcare provider right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing.
  • Kidney injury (glomerulonephritis).UDENYCA can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms:

    • swelling of your face or ankles
    • blood in your urine or dark colored urine
    • you urinate less than usual
  • Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with UDENYCA.
  • Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with UDENYCA. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with UDENYCA. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot.
  • Capillary Leak Syndrome.UDENYCA can cause fluid to leak from blood vessels into your body’s tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:

    • swelling or puffiness and are urinating less than usual
    • trouble breathing
    • swelling of your stomach-area (abdomen) and feeling of fullness
    • dizziness or feeling faint
    • a general feeling of tiredness
  • Myelodysplastic syndrome and acute myeloid leukemia. If you have breast cancer or lung cancer, when UDENYCA is used with chemotherapy and radiation therapy, or with radiation therapy alone, you may have an increased risk of developing a precancerous blood condition called myelodysplastic syndrome (MDS) or a blood cancer called acute myeloid leukemia (AML).Symptoms of MDS and AML may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop these symptoms during treatment with UDENYCA.
  • Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel that transports blood from the heart to the body) has been reported in patients who received pegfilgrastim. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.

The most common side effects of UDENYCA are pain in the bones, arms, and legs.

These are not all the possible side effects of UDENYCA.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store UDENYCA?

  • Store UDENYCA in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • Do not freeze. If UDENYCA is accidentally frozen, allow it to thaw in the refrigerator before injecting.
  • Do not use UDENYCA that has been frozen more than 1 time. Use a new UDENYCA prefilled syringe or prefilled autoinjector.
  • Throw away (dispose of) any UDENYCA that has been left at room temperature, 68ºF to 77ºF (20ºC to 25ºC), for more than 48 hours or frozen more than 1 time.
  • Keep UDENYCA in the original carton to protect from light.
  • Do not shake UDENYCA.
  • Take UDENYCA out of the refrigerator 30 minutes before use and allow it to reach room temperature before preparing an injection.

Keep UDENYCA out of the reach of children.

General information about the safe and effective use of UDENYCA.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use UDENYCA for a condition for which it was not prescribed. Do not give UDENYCA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about UDENYCA that is written for health professionals.

What are the ingredients in UDENYCA?

Active ingredient: pegfilgrastim-cbqv

Inactive ingredients: acetate, polysorbate 20, sodium, and sorbitol in Water for Injection.

Manufactured by: Accord BioPharma, Inc. 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617 USA

U.S. License No. 2105

©2025 Accord BioPharma, Inc. All rights reserved.

For more Information go to www.UDENYCA.com or call 1-866-941-7875

PMD-0006 Rev. xx

This Patient Information has been approved by the U.S. Food and Drug Administration

Revised: 07/2025

Instructions for Use

UDENYCA® (yoo-den-i-kah)

(pegfilgrastim-cbqv)

Injection

Single-Dose Prefilled Syringe

Guide to Parts
Before Use
Important: The needle is covered by a needle cap before use
After Use

Important

Read the Patient Information for important information you need to know about

UDENYCA before using these Instructions for Use.

Storing the UDENYCA prefilled syringe
  • Store UDENYCA prefilled syringes in the refrigerator between 36°F to 46° F (2°C to 8°C).
  • Keep the UDENYCA prefilled syringe in the original carton to protect from light.
  • Do not freeze UDENYCA.

    • If UDENYCA is accidentally frozen, allow the prefilled syringe to thaw in the refrigerator before injecting.
    • Throw away (dispose of) any UDENYCA prefilled syringes that have been frozen more than 1 time.
  • Throw away (dispose of) any UDENYCA prefilled syringes that have been left out at room temperature for more than 48 hours.
  • Keep the UDENYCA prefilled syringe out of the reach of children.
Using the prefilled syringe
  • It is important that you do not try to give the injection unless you or your caregiver has received training from your healthcare provider.
  • Make sure that the name UDENYCA appears on the carton and prefilled syringe label.
  • Check the carton and prefilled syringe label to make sure the dose strength is 6 mg/0.6 mL.
  • You should not inject a dose of UDENYCA to children weighing less than 45 kg from a UDENYCA prefilled syringe. A dose less than 0.6 mL (6 mg) cannot be accurately measured using the UDENYCA prefilled syringe.
  • Do not use a prefilled syringe after the expiration date on the label.
  • Do not shake the prefilled syringe
  • Do not remove the needle cap from the prefilled syringe until you are ready to inject.
  • Do not use the prefilled syringe if the carton is open or damaged.
  • Do not use a prefilled syringe if it has been dropped on a hard surface. The prefilled syringe may be broken even if you cannot see the break. Use a new prefilled syringe.
  • Do not attempt to activate the needle safety guard prior to injection
Call your healthcare provider if you have any questions.
Prepare the injection
1 - Remove carton from refrigerator and check expiration date

1A: Remove the carton from the refrigerator and check the expiration date printed on the carton. (See Figure 3)

Do not use if the expiration date has passed.

1B: Open the carton and remove the sealed syringe tray. (See Figure 4)
2 - Allow UDENYCA to reach room temperature and gather supplies

2A: Place the sealed syringe tray on a flat, clean work surface and allow it to sit at room temperature for at least 30 minutes. (See Figure 5)

Do not attempt to warm up the syringe in any other way, such as a microwave, hot water, or direct sunlight.

2B: Gather the following supplies: (See Figure 6)

  • Alcohol wipe
  • Cotton ball or gauze
  • 1 adhesive bandage
  • Sharps disposal container
3 - Wash your hands and remove syringe from tray
3A: Wash your hands well with soap and warm water. (See Figure 7)

3B: Open the tray by peeling away the cover. Remove the prefilled syringe from the tray by grasping the middle of the syringe body and carefully pulling it out of the tray. (See Figure 8)

For Safety reasons:

  • Do not grab the plunger or the plunger head.
  • Do not grab the needle cap.
4 - Inspect the syringe and medicine

Check the medicine through the Inspection Window. The medicine should be clear and colorless. It is normal to see 1 or more air bubbles in the syringe. Removal of the air is not needed. (See Figure 9)

Do not use the prefilled syringe if:

  • the medicine appears discolored or cloudy.
  • the medicine contains lumps, flakes, or particles.
  • it appears used or damaged.
  • the needle cap is missing or not securely attached.
  • the expiration date printed on the label has passed.

In all cases, use a new prefilled syringe and call your healthcare provider.

Select and clean injection site
5 - Select and clean the injection site

5A: Select the injection site. The recommended injection sites for a subcutaneous injection are the: (See Figure 10)

  • Abdomen (except for a two-inch area surrounding the navel)
  • Thighs
  • Back of upper arms (only if someone else is giving you the injection)
  • Upper outer area of the buttocks (only if someone else is giving you the injection)

Do not inject into moles, scars, birthmarks, or areas where the skin is tender, bruised, red, or hard.

If you want to use the same injection site, make sure it is not the same spot on the injection site you used for a previous injection.

5B: Clean the injection site with an alcohol wipe. (See Figure 11)

Do not touch this area again before injection.

Inject the dose
6 - Remove needle cap

Remove the needle cap by pulling it straight off. (See Figure 12)

  • Do not remove the needle cap from the prefilled syringe until you are ready to inject.
  • Do not twist or bend the needle cap.
  • Do not hold the prefilled syringe by the plunger rod
  • Do not put the needle cap back onto the syringe. Dispose of (throw away) the needle cap in your household trash
  • Do not use the prefilled syringe if it has been dropped with the needle cap removed.
7 – Position fingers

Grasp the body of the syringe like a dart (just under the finger grips) with your thumb and index fingers. (See Figure 13)

  • Do not touch the plunger or grasp the syringe above the finger grips.
8 – Pinch the skin and insert the needle
8A: Use your free hand to gently pinch the cleaned injection site to create a firm surface. (See Figure 14)

8B: Hold the pinch. Insert the needle into the skin at a 45 to 90-degree angle. (See Figure 15)

  • Do not touch the plunger head while inserting the needle into the skin.
  • Do not touch the cleaned area of the skin

8C: After fully inserting the needle, release the pinched skin and use your free hand to stabilize the bottom of the syringe.

Then move your other hand into injection position with your thumb on the plunger head. (See Figure 16)

9 – Push plunger head down to deliver dose
9A: Using slow and constant pressure, push the plunger head down until it reaches the bottom. This will help to ensure that you receive the full dose. (See Figure 17)

9B: While the needle is still inserted, slowly move your thumb back, allowing the plunger to rise. This will release the needle safety guard to safely cover the needle. Then remove the syringe from the injection site. (See Figure 18)

Important: When you remove the syringe, if it looks like the medicine is still in the syringe, this means you have not received a full dose. Call your healthcare provider right away.

  • If you see drops of blood at the injection site, treat by pressing a cotton ball or gauze to the site as needed.
Dispose
10 – Dispose of used prefilled syringes
Put the used prefilled syringe into an FDA-cleared sharps disposal container right away after use. Do not throw away the syringe in the household trash. (See Figure 19)
  • If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:

    • made of a heavy-duty plastic
    • can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out
    • upright and stable during use
    • leak-resistant
    • properly labeled to warn of hazardous waste inside the container
  • When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal.
  • Do not reuse the prefilled syringe.
  • Do not recycle prefilled syringes or sharps disposal container or throw them into household trash.
This Instructions for Use has been approved by the U.S. Food and Drug Administration.Issued: 07/2025

UDENYCA® (pegfilgrastim-cbqv)

Manufactured by: Accord BioPharma, Inc. 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617 USA

U.S. License No. 2105

©2025 Accord BioPharma, Inc. All rights reserved.

For more Information go to www.UDENYCA.com or call 1-866-941-7875

PMD-0005, Rev. xx

INSTRUCTIONS FOR USE

UDENYCA™ (yoo-den-i-kah)

(pegfilgrastim-cbqv)

injection, for subcutaneous use

Single-Dose Prefilled Autoinjector

Storing the UDENYCA prefilled autoinjector

  • Store UDENYCA prefilled autoinjector in the refrigerator between 36°F to 46°F (2°C to 8°C).
  • Keep the UDENYCA prefilled autoinjector in the original carton to protect from light.
  • Do notfreeze UDENYCA.

    • If UDENYCA is accidentally frozen, allow the prefilled autoinjector to thaw in the refrigerator before injecting.
    • Throw away (dispose of) any UDENYCA prefilled autoinjectors that have been frozen more than 1 time.
  • Throw away (dispose of) any UDENYCA prefilled autoinjectors that have been left out at room temperature for more than 48 hours.
  • Keep the UDENYCA prefilled autoinjector out of the reach of children.

Using the UDENYCA prefilled autoinjector

  • It is important that you do not try to give the injection unless you or your caregiver has received training from your healthcare provider.
  • Only adults can self-inject UDENYCA with the prefilled autoinjector.
  • Make sure that the name UDENYCA appears on the carton and prefilled autoinjector label.
  • Check the carton and prefilled autoinjector label to make sure the dose strength is 6 mg/0.6 mL.
  • You should not inject a dose of UDENYCA to children weighing less than 45 kg from an UDENYCA prefilled autoinjector. A dose less than 0.6 mL (6 mg) cannot be accurately measured using the UDENYCA prefilled autoinjector.
  • Do not use a prefilled autoinjector after the expiration date on the label.
  • Do not shake the prefilled autoinjector.
  • Do not remove the clear cap from the prefilled autoinjector until you are ready to inject.
  • Do not use the prefilled autoinjector if the carton is open or damaged.
  • Do not use a prefilled autoinjector if it has been dropped on a hard surface. The prefilled autoinjector may be broken even if you cannot see the break. Use a new prefilled autoinjector.

Call your healthcare provider if you have any questions.

Takethe UDENYCA carton out of the refrigerator.

  • Leave the prefilled autoinjector in the carton at room temperature for 30 minutes before injecting.
  • Do not remove the clear cap while allowing the prefilled autoinjector to reach room temperature.
  • Do not warm the prefilled autoinjector in any other way. For example, do not warm it in a microwave, in hot water, or in direct sunlight.

Check the expiration date on the prefilled autoinjector label. Do notuse the prefilled autoinjector if the expiration date has passed. Place the following supplies on a clean, flat surface:

  • 1 single-dose UDENYCA prefilled autoinjector
  • 1 alcohol wipe (not included)
  • 1 cotton ball or gauze pad (not included)
  • 1 sharps disposal container (not included). See "How should I throw away (dispose of) the used UDENYCA prefilled autoinjector?" in step 10.

Wash and dry your hands.

Choosean injection site.

  • abdomen (except for a two-inch area surrounding the navel)
  • thighs

If someone else is giving you the injection,you can also use the:

  • back of upper arms
  • upper outer area of the buttocks
  • Do not inject into moles, scars, birthmarks, or areas where the skin is tender, bruised, red, or hard.
  • Change (rotate) your injection site with each injection.
  • Do not inject through clothing. Clean the injection site with an alcohol wipe. Let your skin air dry. Do not touch this area again before injection.

Check the viewing window:

  • Hold the prefilled autoinjector with the clear cap facing down.
  • It is normal to see 1 or more air bubbles in the viewing window.
  • Make sure the liquid is clear and colorless.

Do notuse the prefilled autoinjector if:

  • the medicine appears discolored or cloudy.
  • the medicine contains lumps, flakes, or particles.
  • if it has been dropped, crushed or damaged in any way.

Hold the prefilled autoinjector with the clear cap facing up and pullthe clear cap straight off.

  • It is normal to see a few drops of liquid at the end of the needle.
  • Throw away the clear cap.
  • Do not put the clear cap back on the prefilled autoinjector after it has been removed.
  • Do not touch the gray needle guard.

Hold the body of the prefilled autoinjector in one hand so you can see the viewing window.

Place the gray needle guard against your skin at a 90-degree angle.

Press the prefilled autoinjector firmly against the skin and you will hear the first "click".

The orange indicator will start to move along the viewing window.

Keep holding the prefilled autoinjector firmly against the skin until the orange indicator stops moving and you hear the second "click".

After you hear the second "click", continue to hold the prefilled autoinjector in place and count to 5.

When the injection is complete, make sure the orange indicator completely fills the viewing window before slowly lifting the prefilled autoinjector away from the skin.

The gray needle guard will cover the needle tip.

If the viewing window is not completely filled by the orange indicator or if there are more than a few drops of liquid on the injection site, contact your healthcare provider right away. You may not have received your full dose.

After completing the injection, place a cotton ball or gauze pad over the injection site.

  • Do not rub the injection site.
  • Slight bleeding at the injection site is normal.

How should I throw away (dispose of) the used UDENYCA prefilled autoinjector?

  • Put your used prefilled autoinjector in a FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) prefilled autoinjectors in the household trash.
  • If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:

    • made of a heavy-duty plastic,
    • can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
    • upright and stable during use,
    • leak-resistant, and
    • properly labeled to warn of hazardous waste inside the container.
  • When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used prefilled autoinjectors. For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal.
  • Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not reuse the prefilled autoinjector. Do not recycle your used sharps disposal container.

Important: Always keep the sharps disposal container out of reach of children.

  • The clear cap, alcohol swab, cotton ball or gauze pad, and packaging may be placed in your household trash.

This Instructions for Use has been approved by the U.S. Food and Drug Administration.

Issued: 07/2025

Manufactured by: Accord BioPharma, Inc. 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617 USA

U.S. License No. 2105

©2025 Accord BioPharma, Inc. All rights reserved.

For more information, go to www.UDENYCA.com, or call 1-866-941-7875

PMD-0175 Rev. xx

Patient Information

UDENYCA® (yoo-den-i-kah)

(pegfilgrastim-cbqv)

injection

on-body injector for UDENYCA

What is the most important information I need to know about receiving UDENYCA with the on-body injector for UDENYCA?

  • See the Instructions for Use for the on-body injector for UDENYCA for detailed information about the on-body injector for UDENYCA and important information about your dose delivery that has been written by your healthcare provider.

    • Know the time that delivery of your dose of UDENYCA is expected to start.
    • Avoid traveling, driving, or operating heavy machinery during hour 26 through hour 29 after the on-body injector for UDENYCA is applied. Avoid activities and places that may interfere with monitoring during the 5-minute period that UDENYCA is expected to be delivered by the on-body injector for UDENYCA, and for 1 hour after delivery.

  • A caregiver should be with you the first time that you receive UDENYCA with the on-body injector for UDENYCA.
  • Before your next scheduled UDENYCA dose, avoid use of lotions, creams, or oils on your arms and stomach area (abdomen) to help keep the device on your skin.
  • If placed on the back of the arm, a caregiver must be available to monitor the status of the on-body injector.
  • If you have an allergic reaction during the delivery of UDENYCA, remove the on-body injector for UDENYCA by grabbing the edge of the adhesive pad and peeling off the on-body injector for UDENYCA. Get emergency medical help right away.
  • You should only receive a dose of UDENYCA on the day your healthcare provider tells you.
  • You should not receive your dose of UDENYCA any sooner than 24 hours after you finish receiving your chemotherapy. The on-body injector for UDENYCA is programmed to deliver your dose about 27 hours after your healthcare provider fills and places the on-body injector for UDENYCA on your skin.
  • Do notexpose the on-body injector for UDENYCA to the following because the on-body injector for UDENYCA may be damaged, and you could be injured:

    • Diagnostic imaging (e.g., CT scan, MRI, Ultrasound, X-ray)
    • Radiation treatment
    • Oxygen rich environments, such as hyperbaric chambers
  • Avoid airport X-ray scans. Request a manual pat down instead. Use care during a manual pat down to help prevent the on-body injector for UDENYCA from being accidentally removed.
  • Keep the on-body injector for UDENYCA at least 4 inches away from electrical equipment such as cell phones, cordless telephones, microwaves and other common appliances. If the on-body injector for UDENYCA is too close to electrical equipment, it may not work correctly and can lead to a missed or incomplete dose of UDENYCA.
  • The on-body injector is for adult patients only.
  • If your on-body injector is not working properly, you may miss your dose or you may not receive your full dose of UDENYCA. If you miss your dose or do not receive your full dose of UDENYCA, you may have an increased risk of developing fever or infection.
  • Call your healthcare provider right away, as you may need a replacement dose, if any of the following occur:

    • on-body injector for UDENYCA comes off before or during a dose delivery. Do not re-apply it.
    • on-body injector for UDENYCA is leaking.
    • adhesive on your on-body injector for UDENYCA becomes noticeably wet (saturated) with fluid, or there is dripping. This may mean that UDENYCA is leaking out of your on-body injector for UDENYCA. If this happens you may only receive some of your dose of UDENYCA, or you may not receive a dose at all.
    • on-body injector for UDENYCA status light is flashing red.

What is UDENYCA?

UDENYCA is a prescription medicine used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low blood cell count.

Do not take UDENYCA if you have had a serious allergic reaction to pegfilgrastim products or filgrastim products.

Before you receive UDENYCA, tell your healthcare provider about all of your medical conditions, including if you:

  • have a sickle cell disorder.
  • have had severe skin reactions to acrylic adhesives.
  • have kidney problems.
  • are pregnant or plan to become pregnant. It is not known if UDENYCA may harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if UDENYCA passes into your breast milk.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive UDENYCA?

See the Instructions for Use for detailed information about how you will receive a dose of UDENYCA with the on-body injector for UDENYCA, and how to remove and dispose of the on-body injector for UDENYCA.

  • See the section "What is the most important information I need to know about receiving UDENYCA with the on-body injector for UDENYCA?"
  • UDENYCA is given as an injection under the skin (subcutaneous). Your healthcare provider will use a prefilled syringe with UDENYCA to fill the on-body injector prior to applying it. The prefilled syringe with UDENYCA and the on-body injector are provided to your healthcare provider as part of UDENYCA ONBODY. The on-body injector for UDENYCA will be applied to the stomach area (abdomen) or back of your arm by your healthcare provider. If the on-body injector for UDENYCA was placed on the back of your arm, a caregiver must be available to monitor the on-body injector for UDENYCA.
  • Your healthcare provider should place the on-body injector for UDENYCA on an area of your skin that does not have swelling, redness, cuts, wounds, or abrasions. Tell your healthcare provider about any skin reactions that happen in the on-body injector for UDENYCA application area after it has been applied.
  • The on-body injector for UDENYCA is programmed to deliver your dose about 27 hours after your healthcare provider places the on-body injector for UDENYCA on your skin.
  • The dose of UDENYCA will be delivered over about 5 minutes. During dose delivery and for 1 hour after delivery, it is best to stay in a place where you or a caregiver can monitor the on-body injector for UDENYCA to make sure you receive your full dose of UDENYCA and watch for symptoms of an allergic reaction.
  • Your healthcare provider will show you how to monitor the on-body injector for UDENYCA to make sure delivery has been completed.
  • Keep the on-body injector for UDENYCA dry for about the last 3 hours before the dose delivery is expected to start. This will help you to better detect possible leaking from the on-body injector for UDENYCA.
  • Only expose the on-body injector for UDENYCA to temperatures between 41°F to 104°F (5°C to 40°C).

While the on-body injector for UDENYCA is in place you should avoid:

  • traveling, driving, or operating heavy machinery during hour 26 through hour 29 after the on-body injector for UDENYCA is applied.
  • sleeping on the on-body injector for UDENYCA or applying pressure on the on-body injector for UDENYCA. The on-body injector for UDENYCA may not work properly.
  • bumping the on-body injector for UDENYCA or knocking it off your body.
  • using other materials to hold the on-body injector in place. Using other materials could cover audio or visual indicators or press the on-body injector against your skin, and lead to a missed dose or incomplete dose of UDENYCA.
  • getting body lotion, creams, oils, and skin cleansing products near the on-body injector for UDENYCA. These products may loosen the adhesive that holds the on-body injector for UDENYCA onto your body.
  • using bathtubs, hot tubs, whirlpools, or saunas, and direct sunlight. These may affect UDENYCA.
  • peeling off or disturbing the on-body injector for UDENYCA adhesive before you receive your full dose of UDENYCA.

What are the possible side effects of UDENYCA?

UDENYCA may cause serious side effects, including:

  • Spleen rupture. Your spleen may become enlarged and can rupture. A ruptured spleen can cause death. Call your healthcare provider right away if you have pain in your left upper stomach area or left shoulder.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you have shortness of breath with or without a fever, trouble breathing, or a fast rate of breathing.
  • Serious allergic reactions. UDENYCA can cause serious allergic reactions. These reactions can cause a rash over your whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating.

    If you have an allergic reaction during the delivery of UDENYCA, remove the on-body injector for UDENYCA by grabbing the edge of the adhesive pad and peeling off the on-body injector for UDENYCA. Get emergency medical help right away.

  • Sickle cell crises. You may have a serious sickle cell crisis, which could lead to death, if you have a sickle cell disorder and receive UDENYCA. Call your healthcare provider right away if you develop symptoms of sickle cell crisis such as pain or difficulty breathing.
  • Kidney injury (glomerulonephritis).UDENYCA can cause kidney injury. Call your healthcare provider right away if you develop any of the following symptoms:

    • swelling of your face or ankles
    • blood in your urine or dark colored urine
    • you urinate less than usual
  • Increased white blood cell count (leukocytosis). Your healthcare provider will check your blood during treatment with UDENYCA.
  • Decreased platelet count (thrombocytopenia). Your healthcare provider will check your blood during treatment with UDENYCA. Tell your healthcare provider if you have unusual bleeding or bruising during treatment with UDENYCA. This could be a sign of decreased platelet counts, which may reduce the ability of your blood to clot.
  • Capillary Leak Syndrome.UDENYCA can cause fluid to leak from blood vessels into your body’s tissues. This condition is called “Capillary Leak Syndrome” (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:

    • swelling or puffiness and are urinating less than usual
    • trouble breathing
    • swelling of your stomach-area (abdomen) and feeling of fullness
    • dizziness or feeling faint
    • a general feeling of tiredness
  • Myelodysplastic syndrome and acute myeloid leukemia. If you have breast cancer or lung cancer, when UDENYCA is used with chemotherapy and radiation therapy, or with radiation therapy alone, you may have an increased risk of developing a precancerous blood condition called myelodysplastic syndrome (MDS) or a blood cancer called acute myeloid leukemia (AML). Symptoms may include tiredness, fever, and easy bruising or bleeding. Call your healthcare provider if you develop these symptoms during treatment with UDENYCA.
  • Inflammation of the aorta (aortitis). Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported in patients who received pegfilgrastim products. Symptoms may include fever, abdominal pain, feeling tired, and back pain. Call your healthcare provider if you experience these symptoms.

The most common side effect of UDENYCA is pain in your bones, and in your arms, and legs. These are not all the possible side effects of UDENYCA. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

General information about the safe and effective use of UDENYCA.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. If you would like more information about UDENYCA, talk with your healthcare provider or pharmacist. You can ask your pharmacist for information about UDENYCA that is written for health professionals.

What are the ingredients in UDENYCA?

Active ingredient: pegfilgrastim-cbqv

Inactive ingredients: acetate, polysorbate 20, sodium, and sorbitol in Water for Injection.

Manufactured by: Accord BioPharma, Inc. 8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617 USA

U.S. License No. 2105

©2025 Accord BioPharma, Inc. All rights reserved.

For more information go to www.UDENYCA.com, or call 1-866-941-7875

PMD-0213, Rev.xx

This Patient Information has been approved by the U.S. Food and Drug Administration.

Issued: 07/2025

07Healthcare Provider INSTRUCTIONS FOR USE

UDENYCA (yoo-den-i-kah) ONBODY™

(pegfilgrastim-cbqv)

injection, for subcutaneous use

Guide to Parts

UDENYCA Prefilled Syringe

On-body Injector for UDENYCA

Important

READ THE FOLLOWING INSTRUCTIONS BEFORE USING UDENYCA ONBODY

Prescribing Information

  • See Prescribing Information for information on UDENYCA.
  • The on-body injector is for adult patients only.
  • The on-body injector is not recommended for patients with Hematopoietic Subsyndrome of Acute Radiation Syndrome.
  • For patients who have had severe skin reactions to acrylic adhesives, consider the benefit-risk profile before administering pegfilgrastim via the on-body injector for UDENYCA.

Application Information

  • The on-body injector should be applied to intact, non-irritated skin on the abdomen or back of the arm. The back of the arm may only be used if there is a caregiver available to monitor the status of the on-body injector.
  • The on-body injector has a self-adhesive backing to attach it to the skin, do not use additional materials to hold it in place as this could lead to a missed or incomplete dose of UDENYCA.

Environmental Information

  • Do notexpose the on-body injector for UDENYCA to the following environments as the on-body injector may be damaged and the patient could be injured:

    • Diagnostic imaging (e.g., CT Scan, MRI, Ultrasound, X-ray)
    • Radiation treatment
    • Oxygen rich environments such as hyperbaric chambers.

Cautions

  • Do not use UDENYCA ONBODY to deliver any other drug product.
  • Do not use the on-body injector if its packaging has been previously opened, or the expiration date on the carton or any components has passed.
  • Do not use if the name UDENYCA does not appear on UDENYCA ONBODY carton.
  • Do not modify the on-body injector.
  • Do not fill the UDENYCA on-body injector on the adhesive side. Use the metal medicine port.
  • Do not attempt to reapply the on-body injector.
  • Do not use if either the on-body injector or prefilled syringe is dropped. Start again with a new on-body injector or prefilled syringe.

Storage Information

  • Store the ONBODY in the refrigerator at 36°F to 46°F (2°C to 8°C) until ready for use. If the ONBODY is stored at room temperature for more than 12 hours, do not use. Start again with a new ONBODY.
  • Keep the prefilled syringe in the carton until use to protect from light.
  • Do not freeze the ONBODY.
  • Do not separate the components of UDENYCA ONBODY until ready for use.

For all questions, call Accord BioPharma, Inc. at 1-866-941-7875. If a patient calls you regarding any on-body injector problems, call Accord BioPharma, Inc. at 1-866-941-7875.

Step 1: Prepare

A| Remove ONBODY from the refrigerator and open carton.

Place the syringe tray and on-body injector tray on a clean, flat, well-lit work surface. Allow to come to room temperature for 30 minutes prior to use. Do not warm the UDENYCA ONBODY components using a heat source.

Check to make sure it contains:

  • One UDENYCA prefilled syringe
  • One on-body injector for UDENYCA
  • UDENYCA Patient Information
  • UDENYCA Prescribing Information
  • Instructions for Use for healthcare provider
  • Instructions for Use for patient

Check the above listed items for damage and check the expiry date on the syringe tray and on-body injector tray.

Do notuse the on-body injector:

  • if its packaging has been previously opened
  • if the packaging or trays appear to be damaged or have been dropped
  • if the expiry date on the syringe tray or on-body injector tray has passed.

B| Choose the patient’s injection site.

Choose the flattest site for the on-body injector application.

Ask the patient about their ability to monitor and remove the on-body injector.

  • You can use the left or right side of the abdomen, except for a two-inch area right around navel.
  • You can use the back of upper arm only if there is a caregiver available to monitor the status of the on-body injector.
  • Apply the on-body injector to intact, non-irritated skin.
  • Do not apply the on-body injector on areas with scar tissue, moles, or excessive hair. In case of excessive hair, carefully trim hair to get the on-body injector close to the skin.
  • Do not apply the on-body injector on areas where belts, waistbands, or tight clothing may rub against, disturb, or dislodge the on-body injector.
  • Do not apply the on-body injector on surgical sites.
  • Do not apply the on-body injector on areas where the on-body injector will be affected by folds in the skin.

C| Clean an area on the injection site larger than the on-body injector adhesive backing.

  • Thoroughly clean the site with alcohol to enhance on-body injector‘s adherence to the skin. Only use alcohol to clean the skin.
  • Make sure the skin is oil-free prior to applying the on-body injector.
  • Allow the skin to completely dry on its own (e.g. without blowing on or fanning the area) before attaching the on-body injector.
  • Do not touch this area again before attaching the on-body injector.

Step 2: Get ready

A| Open on-body injector tray and remove plastic lid.

Wash your hands before use.

Open the on-body injector tray by fully removing the tray cover and removing the plastic lid.

  • Do not remove the on-body injector from the tray before filling it.
  • Do not remove the green fill guide.

B| Remove UDENYCA prefilled syringe from tray.

For safety reasons:

  • Do not grasp the gray needle cap.
  • Do not remove the gray needle cap until ready to fill the on-body injector.
  • Do not grasp the plunger rod.

C| Inspect medicine and UDENYCA prefilled syringe. UDENYCA liquid should always be clear and colorless.

  • Do not use if the liquid contains particulate matter or discoloration is observed prior to administration.
  • Do not use if any part appears to be damaged, cracked or broken.
  • Do not use if the gray needle cap is missing or not securely attached.
  • Do not use if the expiration date printed on the label has passed.
  • Do not remove the gray needle cap until ready to fill the on-body injector.
  • Do not shake the prefilled syringe.

In all the above cases, start again with a new UDENYCA ONBODY. Call Accord BioPharma at 1-866-941-7875.

D| Remove air bubbles in prefilled syringe. E| Orient the syringe with the needle facing downwards. Center the needle directly over the metal medicine port at a 90-degree angle. Insert the needle all the way into the port, avoiding sides.

Insert needle into metal medicine port at a 90-degree angle only.

  • Do not fill the UDENYCA on-body injector on the adhesive side. Use the metal medicine port.
  • Do not touch the plunger until the needle is fully inserted into the metal medicine port.
  • Do not move the needle in the metal medicine port.
  • Do not insert the needle more than once.
  • Do not bend the needle. Avoid spilling the medicine.
  • Do not remove the green fill guide before filling the on-body injector.
F| Fully depress the plunger rod to expel entire contents of the prefilled syringe into the on-body injector.

After filling completely, you will hear two beeps. The status light will start to flash green.

Remove the needle straight from the metal medicine port and dispose the empty syringe right away into a puncture proof container.

  • Do not recap the needle.
G| Check to see if the on-body injector is full.

You should see the green status light flashing and a black line next to FULL on the fill indicator. If this is not the case, do not use.

Start again with a new UDENYCA ONBODY, and call Accord BioPharma at 1-866-941-7875.

H| Remove on-body injector from tray, then firmly squeeze and lift the green fill guide away from the on-body injector. Dispose of green fill guide.

A drop of medicine may be visible

on the metal medicine port when the green fill

guide is removed.

Step 3: Apply

A| Peel away both pull tabs to show the adhesive. Never touch hands or gloves to the adhesive.

Make sure skin is dry prior to applying the on-body injector.

  • Do not touch or contaminate the automatic needle opening.
  • Do not pull off the adhesive pad or fold it.
  • Do not place adhesive on skin that is damp.

In all cases, start again with a new UDENYCA ONBODY.

Call Accord BioPharma at 1-866-941-7875.

B| Securely apply the on-body injector without folding and without wrinkling to the cleaned injection site so it is visible and can be monitored by the patient or caregiver.

  • Do not touch the adhesive.
  • Grasp the on-body injector’s plastic case with your fingertips and only by sides, keeping fingers off of the adhesive.
  • Do not et the adhesive bend or curl while applying the on-body injector to skin.

Back of upper arm (triceps)

Vertical with the light facing down toward the elbow

Abdomen

Horizontal with the light facing up and visible to the patient

If the adhesive is wrinkled or has folds anywhere that prevent the on-body injector from securely adhering, remove the on-body injector. Start again with a new ONBODY and call Accord BioPharma at 1-866-941-7875 (1-800-483-3692).

Step 4: Finish

A| Provide the Patient Instructions for Use Booklet for the patient to take home. Fill in the Dose Delivery information on the Patient Instructions for Use Booklet, and review the following instructions with your patient:

  • The on-body injector will always flash a slow green light to let them know it is working properly.
  • The patient should keep the on-body injector dry for at least 3 hours after it was placed on their skin.
  • After approximately 27 hours the on-body injector will start to deliver the dose.
  • Immediately before dose delivery starts the injection needle will be automatically inserted into the skin.
  • When the dose delivery starts it will take about 5 minutes to complete. During this time, the on-body injector will flash a fast green light.
  • When dose delivery is complete, the on-body injector will sound a long beep, and the status light will turn SOLID GREEN. The needle will retract automatically.
  • Do not remove the on-body injector until the status light is SOLID GREEN.
  • If the red error light is flashing, or the adhesive is noticeably wet (saturated), or the on-body injector is dislodged, the patient should contact their healthcare provider immediately as they may need a replacement dose.
  • The patient should remain in a place where they can monitor the on-body injector for the entire dose delivery. The patient should avoid activities and settings that may interfere with wearing and monitoring during the dosing of UDENYCA administered by the on-body injector or could cause the OBI to fall off. For example, avoid traveling, driving, or operating heavy machinery during hours 26-29 following application of the on-body injector (this includes the approximately 5-minute delivery period plus an hour post-delivery).
  • If the patient has an allergic reaction during the delivery of UDENYCA, the patient should remove the on-body injector and call his or her healthcare provider or seek emergency care right away.
  • If placed on the back of the arm, remind the patient that a caregiver must be available to monitor the on-body injector.
  • The on-body injector has a self-adhesive backing to attach it to the skin.
  • Do not use other materials to hold it in place as this could cover audio/visual indicators or compress the on-body injector against the patient’s skin, as this could lead to a missed or incomplete dose of UDENYCA.
  • Always dispose of the empty on-body injector in a sharps disposal container as instructed by your healthcare provider or by state or local laws.
  • Keep the on-body injector at least four inches away from electrical equipment such as cell phones, cordless telephones, microwaves and other common appliances. Failure to keep the on-body injector at least this recommended distance may interfere with operation and can lead to a missed or incomplete dose of UDENYCA.

If at any time the on-body injector beeps continuously for five minutes, and the status light is flashing red, take the on-body injector off of the patient.

  • Do not apply the on-body injector to the patient if red error light is on.
  • Do not leave the on-body injector on the patient if red error light is on.

In all cases, do not use. Start over with a new UDENYCA ONBODY, and call 1-866-941-7875.

If the patient reports the red status light is on, they may not have received the full dose. Schedule a follow-up appointment and report the incident to Accord BioPharma at 1-866-941-7875.

If the patient reports an on-body injector leak, they may not have received the full dose. Schedule a follow-up appointment and report the incident to Accord BioPharma at 1-866-941-7875.

Manufactured by:

Accord BioPharma, Inc.

8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617 USA

U.S. License No. 2105

https://udenyca.com

1-866-941-7875

Issued: 07/2025

PMD-0214 Rev. xx

Electromagnetic Compatibility

The delivery system is designed to conform to the electromagnetic compatibility (EMC) standard IEC 60601-1-2:2020 and to operate accurately in conjunction with other medical equipment which also meets the requirements of this standard under home and hospital use environments.

To avoid electromagnetic interference (EMI) that may affect the performance of the delivery system [(i) Dose accuracy, (ii) treatment duration, (iii) Injection Depth, (iv) Visual and audible feedback], do not use the delivery system near sources of strong electric and magnetic interference (EMI), such as MRI, ionizing radiation, CT, diathermy, electromagnetic security systems (e.g., metal detectors), and large electric motors. In addition, portable and mobile RF communication equipment, such as RF emitters, cellular telephones, 2- way radios, BluetoothTM devices, and microwave ovens in close proximity to this device may affect the operation of the delivery system. Some of these EMI sources (mostly RF emitters) may not be visible and the device can potentially be exposed to fields from these EMI sources without the user’s awareness.

If you identify or suspect that external RF sources or other equipment are influencing delivery system operation (from known or unknown sources), try to (as applicable) increase the delivery system distance from the EMI source.

Electromagnetic Emissions

The delivery system has been tested and found to comply with the limits for a Class B digital device, pursuant to Part 15 of the FCC rules. These limits are designed to provide reasonable protection against harmful interference in a residential installation.

If this delivery system does cause harmful interference to radio or television reception, which can be determined by turning the radio or television off and on, the user is encouraged to try to correct the interference by one or more of the following measures: Reorient or relocate the receiving antenna. Increase the separation between the equipment and receiver. Connect the radio or television to an outlet on a circuit different from that to which the receiver is connected. Consult the dealer or an experienced radio/TV technician.

Electromagnetic Immunity

The delivery system has been tested to comply in either a Home Healthcare Environment or Professional Healthcare Environment.

Proximity fields from RF wireless communications equipment Immunity

The delivery system is tested per IEC 61000-4-3 at Frequencies and Levels as specified below to ensure Enclosure Port Immunity to RF wireless communications equipment.

WARNING: Portable RF communications equipment (including peripherals such as antenna cables and external antennas) should be used no closer than 30 cm (12 inches) to any part of the Delivery System. Otherwise, degradation of the performance of this equipment could result.

WARNING: Use of this delivery system adjacent to other equipment should be avoided because it could result in improper operation. If such use is necessary, this equipment and the other equipment should be observed to verify that they are operating normally.

Symbols Glossary

DescriptionSymbol/Sub clause
Name or trade mark of the product
Part number
Name or trade name and address of the manufacturer
Serial number or batch code, preceded by the word 'LOT', or the serial number/NDC number;
Warnings and/or precautions to take (in text format)
Storage temperature and any other special storage and/or handling conditions (for the combination)
Humidity limitation (for the combination)
Pressure limitation (for the combination)
Do not use if package is damaged
Keep away from sunlight
Keep dry
For electrical devices - Water and dust ingress rating
For electrical devices – refer to instruction for use
"Rx only" labeling of prescription devices
Sterile & Sterilization by EO
Expiration date (Use by)
The device is for single use
Should not enter the MRI scanner room
Type BF applied parts
CSA Certificate
Battery specification Li-MnO2 Battery 3V/850mAH (CR14250)N/A
WEEE directive compliance
UDENYCA® (pegfilgrastim-cbqv) prefilled syringe
On-body injector for UDENYCA® (pegfilgrastim-cbqv)

Patient INSTRUCTIONS FOR USE

UDENYCA (yoo-den-i-kah) ONBODY™

(pegfilgrastim-cbqv)

injection, for subcutaneous use

Dose Delivery Information
Get to Know Your On-body Injector

Flashing Green: The on-body injector is working properly. Do not remove the on-body injector if the status light is flashing green.

Solid Green (or off): Signals dose delivery is complete. Check to see if fill indicator reads empty.

Flashing Red: On-body injector error. If you hear beeping at any time, check the status light. If it is flashing red, call your healthcare provider right away as you may need a replacement dose.

Fill indicator: Black line shows how much UDENYCA is in the on-body injector.

Important Information

On-body Injector for UDENYCA Description

  • The on-body injector for UDENYCA is intended for delivery of UDENYCA. This on-body injector delivers UDENYCA with an injection under-the-skin (subcutaneous). See the Patient Information that comes with your on-body injector for important information.
  • Your healthcare provider will use a prefilled syringe with UDENYCA to fill the on-body injector prior to applying it. The prefilled syringe with UDENYCA and the on-body injector are provided to your healthcare provider as part of UDENYCA ONBODY. The on-body injector is applied directly to your skin using a self- adhesive backing. The on-body injector lets you know its status with sounds and lights.

Warnings

  • You should only receive a dose of UDENYCA on the day your healthcare provider tells you.
  • You should not receive your dose of UDENYCA any sooner than 24 hours after you finish receiving your chemotherapy. The on-body injector for UDENYCA is programmed to deliver your dose about 27 hours after your healthcare provider places the on-body injector on your skin.
  • If you have concerns about your medicine, call your healthcare provider right away. Serious allergic reactions can happen with UDENYCA. Ask your caregiver to be nearby for the first use. Plan to be in a place where you or your caregiver can closely monitor the on-body injector for UDENYCA for about 5-minutes during UDENYCA delivery and for an hour after the delivery.
  • Do not take UDENYCA if you have had a serious allergic reaction to pegfilgrastim products or to filgrastim products.
  • Tell your healthcare provider if you have had severe skin reactions to acrylic adhesives.
  • If you have an allergic reaction during the delivery of UDENYCA, remove the on- body injector by grabbing the edge of the adhesive pad and peeling off the on- body injector. Get emergency medical help right away. Caution the needle may be exposed. Dispose of the on-body injector into a sharps disposal container right away.
  • Call your healthcare provider right away if you have severe pain or skin discomfort around your on-body injector.
  • Call your healthcare provider right away if you have pain in your left upper stomach area or left shoulder area. This pain could mean your spleen is enlarged or ruptured.
  • Call your healthcare provider or get emergency medical help right away if you get any of these symptoms of acute respiratory distress syndrome (ARDS): fever, shortness of breath, trouble breathing, or a fast rate of breathing.
  • Call your healthcare provider right away if you experience any of these symptoms of kidney injury (glomerulonephritis): puffiness in your face or ankles, blood in your urine or brown colored urine or you notice you urinate less than usual.
  • Call your healthcare provider if you have persistent or worsening redness or tenderness at the application site (may be a sign of infection).
  • The on-body injector is for adult patients only.

Wearing the On-body Injector

  • This on-body injector delivers UDENYCA with an under-the-skin (subcutaneous) injection.
  • The on-body injector is small, for one-time use, lightweight, battery-powered, and waterproof up to 5 feet (1.5 meters) for 1 hour.
  • The on-body injector can be worn in a shower. After showering, check the on- body injector to make sure it has not become loose (dislodged).
  • Avoid getting body lotions, creams, oils or cleaning agents near the on-body injector as these products may loosen the adhesive. Before your next scheduled UDENYCA dose, avoid use of lotions, creams, or oils on your arms and stomach area (abdomen).
  • Only expose the on-body injector to temperatures between 41°F and 104°F (5°C and 40°C).
  • Do not use bathtubs, hot tubs, whirlpools, or saunas while wearing the on-body injector. This may affect your medicine.
  • Do not expose the on-body injector to direct sunlight. If the on-body injector is exposed to direct sunlight for more than 1 hour, it may affect your medicine. Wear the on-body injector under clothing.
  • Do not sleep on the on-body injector or apply pressure during wear, especially during dose delivery. This may affect on-body injector performance.
  • Do not peel off or disturb the on-body injector adhesive before your full dose is complete. This may result in a missed or incomplete dose of UDENYCA.

Environmental Precautions

  • Do notexpose the on-body injector to the following because the on-body injector may be damaged and you could be injured:

    • Diagnostic imaging (e.g., CT Scan, MRI, Ultrasound, X-ray)
    • Radiation treatment
    • Oxygen rich environments, such as hyperbaric chambers.
  • Keep the on-body injector at least 4 inches away from electrical equipment such as cell phones, cordless telephones, microwaves and other common appliances. Failure to keep the on-body injector at least this recommended distance may interfere with operation and can lead to a missed or incomplete dose of UDENYCA.
  • Avoid activities and places that may interfere with monitoring during the dosing of UDENYCA administered by the on-body injector. For example, avoid traveling, driving, or operating heavy machinery during hours 26-29 following application of the on-body injector for UDENYCA (this includes the 5-minute dose delivery period plus an hour post-delivery).
  • If you must travel by airplane before the approximately 5-minute dose delivery period with the on-body injector, avoid airport X-ray scans. Request a manual pat down instead. Use care during a manual pat down to help prevent the on-body injector from being accidentally removed. For more information go to: http://www.tsa.gov/travelerinformation/travelers-disabilities-and-medical-conditions

A healthcare provider who is familiar with UDENYCA should answer your questions. For general questions or support call 1-866-941-7875 or visit www.udenyca.com.

Step 1: Monitor On-body Injector

A| For the next 27 hours, occasionally check the status light for at least 10 seconds. If the status light is flashing green, it is okay.

  • Keep the on-body injector and adhesive backing dry for at least 3 hours after it was placed on your skin, and for 3 hours prior to dose delivery.
  • Be careful not to bump the on-body injector, or knock the on-body injector off your body.
  • The on-body injector has a self-adhesive backing to attach it to the skin. Do not add other materials to hold it in place as this could lead to a missed or incomplete dose of UDENYCA.
  • If the on-body injector was placed on the back of your arm, a caregiver must be available to monitor the status of the on-body injector.
  • If the on-body injector comes away from your skin at any time, do not reapply it. Call your healthcare provider right away as you may need a replacement dose. Caution the needle may be exposed. Dispose of the on-body injector into a sharps disposal container right away.
  • If you hear beeping at any time, check the status light. If it is flashing red, call your healthcare provider right away, as you may need a replacement dose.

Step 2: Observe Dose Delivery

A| After about 27 hours, your on-body injector will begin to deliver your dose of UDENYCA.

  • Right before the injection starts the injection needle will be automatically inserted into the skin.
  • Dose delivery will take around 5-minutes to complete. The on-body injector will flash a fast, green light.
  • You may hear the pump working. This is okay.
  • When dose delivery is complete, a long beep will sound and the status light will turn solid green.
  • If you hear beeping at any time, check the status light. If it is flashing red, call your healthcare provider right away, as you may need a replacement dose.
  • If the adhesive is noticeably wet or dripping with medicine, call your healthcare provider right away, as you may need a replacement dose.

Step 3: Verify Dose Complete

A| After the beep, check the color of the status light. B| Grab the edge of the adhesive pad. Slowly peel off the on-body injector.

  • Do not grasp the on-body injector itself to try to pull it off of your body.
  • If medicine has leaked or the adhesive is noticeably wet or dripping, call your healthcare provider right away, as you may not have received your full dose and you may need a replacement dose.
  • Remove any extra adhesive using soap and water.

Step 4: Finish

  • Check your status light. Watch for at least 10 seconds. If the status light is solid green or it has switched off, it is okay.
  • You should see a black line next to the EMPTY indicator. If the on-body injector is not empty, call your healthcare provider right away, as you may need a replacement dose.
  • If you hear beeping, or when you check the status light and it is flashing red, call your healthcare provider right away.
  • If the needle is exposed, call your healthcare provider right away.

A| Check off the box below to record how your on-body injector looks after use. B| Properly dispose of the on-body injector.

  • After on-body injector removal, place the on-body injector in a sharps disposal container whether the needle is exposed or not.
  • The on-body injector contains batteries, electronics, and a needle. Put the on-body injector in a FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) the on-body injector in your household trash.
  • If you do not have a FDA-cleared sharps disposal container, you may use a household container that is:

    • made of a heavy-duty plastic,
    • can be closed with a tight-fitting, puncture-resistant lid, without sharps being able to come out,
    • upright and stable during use,
    • leak-resistant, and
    • properly labeled to warn of hazardous waste inside the container.
  • When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and syringes.
  • Do not dispose of your used sharps disposal container in your household trash unless your community guidelines permit this. Do not recycle your used sharps disposal container.
  • For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to FDA's website at: http://www.fda.gov/safesharpsdisposal.
  • Keep the used on-body injector and sharps disposal container away from children.

Frequently Asked Questions

How do I know it is safe to remove the on-body injector? It is safe to remove the on-body injector after checking the following:

  • The status light should be solid green.
  • If the status light is flashing green, the dose delivery is not complete. Wait until you hear a long beep and the status light turns solid green before removing your on-body injector.
  • The status light turns off 1 hour after delivery completion.
  • The fill indicator should have a black line next to EMPTY.
  • If the status light is flashing red, you may not have received your full dose and may need a replacement dose. Call your healthcare provider right away.

Call your healthcare provider right away if the on-body injector at any time comes away from your skin before your full dose delivery, as you may need a replacement dose.

Do not reapply it. Caution the needle may be exposed. Dispose of the on-body injector into a sharps disposal container right away. If there is blood, press a clean cotton ball or gauze pad on the application site. Apply an adhesive bandage if needed. Call your healthcare provider right away if you experience persistent or worsening redness or tenderness at the application site, as this can be a sign of infection.

Manufactured by:

Accord BioPharma, Inc.

8041 Arco Corporate Drive, Suite 200, Raleigh, NC 27617 USA

U.S. License No. 2105

https://udenyca.com

1-866-941-7875

Issued: 07/2025

PMD-0215 Rev. xx

Electromagnetic Compatibility

The delivery system is designed to conform to the electromagnetic compatibility (EMC) standard IEC 60601-1-2:2020 and to operate accurately in conjunction with other medical equipment which also meets the requirements of this standard under home and hospital use environments.

To avoid electromagnetic interference (EMI) that may affect the performance of the delivery system [(i) Dose accuracy, (ii) treatment duration, (iii) Injection Depth, (iv) Visual and audible feedback], do not use the delivery system near sources of strong electric and magnetic interference (EMI), such as MRI, ionizing radiation, CT, diathermy, electromagnetic security systems (e.g., metal detectors), and large electric motors. In addition, portable and mobile RF communication equipment, such as RF emitters, cellular telephones, 2- way radios, BluetoothTM devices, and microwave ovens in close proximity to this device may affect the operation of the delivery system. Some of these EMI sources (mostly RF emitters) may not be visible and the device can potentially be exposed to fields from these EMI sources without the user’s awareness.

If you identify or suspect that external RF sources or other equipment are influencing delivery system operation (from known or unknown sources), try to (as applicable) increase the delivery system distance from the EMI source.

Electromagnetic Emissions

The delivery system has been tested and found to comply with the limits for a Class B digital device, pursuant to Part 15 of the FCC rules. These limits are designed to provide reasonable protection against harmful interference in a residential installation.

If this delivery system does cause harmful interference to radio or television reception, which can be determined by turning the radio or television off and on, the user is encouraged to try to correct the interference by one or more of the following measures: Reorient or relocate the receiving antenna. Increase the separation between the equipment and receiver. Connect the radio or television to an outlet on a circuit different from that to which the receiver is connected. Consult the dealer or an experienced radio/TV technician.

Electromagnetic Immunity

The delivery system has been tested to comply in either a Home Healthcare Environment or Professional Healthcare Environment.

Proximity fields from RF wireless communications equipment Immunity

The delivery system is tested per IEC 61000-4-3 at Frequencies and Levels as specified below to ensure Enclosure Port Immunity to RF wireless communications equipment.

WARNING: Portable RF communications equipment (including peripherals such as antenna cables and external antennas) should be used no closer than 30 cm (12 inches) to any part of the Delivery System. Otherwise, degradation of the performance of this equipment could result.

WARNING: Use of this delivery system adjacent to other equipment should be avoided because it could result in improper operation. If such use is necessary, this equipment and the other equipment should be observed to verify that they are operating normally.

Symbols Glossary

DescriptionSymbol/Sub clause
Name or trade mark of the product
Part number
Name or trade name and address of the manufacturer
Serial number or batch code, preceded by the word ‘LOT’, or the serial number/NDC number;
Warnings and/or precautions to take (in text format)
Storage temperature and any other special storage and/or handling conditions (for the combination)
Humidity limitation (for the combination)
Pressure limitation (for the combination)
Do not use if package is damaged
Keep away from sunlight
Keep dry
For electrical devices - Water and dust ingress rating
For electrical devices – refer to instruction for use
"Rx only" labeling of prescription devices
Sterile & Sterilization by EO
Expiration date (Use by)
The device is for single use
Should not enter the MRI scanner room
Type BF applied parts
CSA Certificate
Battery specification Li-MnO2 Battery 3V/850mAH (CR14250)N/A
WEEE directive compliance
UDENYCA® (pegfilgrastim-cbqv) prefilled syringe
On-body injector for UDENYCA® (pegfilgrastim-cbqv)

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: BLA 761039 · View the label on DailyMed

Revision date stated in the text: July 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Udenyca

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Leukocyte Growth Factor
Active ingredient Pegfilgrastim 6 mg/0.6 mL
Dosage form Injection, solution
Route Subcutaneous
Marketing status listed in the FDA NDC Directory
Company (applicant) COHERUS BIOSCIENCES INC
FDA approval BLA 761039Biologics License Application (BLA) Approved November 2, 2018
Manufacturers 2 labelers list this drug on DailyMed
Recalls
  • January 16, 2026: Class I recall: Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.
Packages (NDC)
Package
6 mg/0.6 mL – 0.6 ml in 1 syringe / 1 in 1 carton
6 mg/0.6 mL – 0.6 ml in 1 syringe / 1 in 1 carton
6 mg/0.6 mL – 0.6 ml in 1 syringe / 1 in 1 carton

Source: FDA drug labeling via NLM DailyMed, data as of November 5, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.